Results 61 to 70 of about 7,115 (194)

Effect of olmesartan on oxidative stress in hemodialysis patients. [PDF]

, 2008
The effect of olmesartan, an inverse angiotensin II type 1 receptor blocker (ARB), on oxidative stress in hemodialysis (HD) patients is not fully understood, and has not been widely investigated in vitro or in vivo.
45138, 9000283797567, 45137, 安楽, 誠, 冨田, 公夫, 45139, 45136, 1000090423657, 9000001980702, 9000014554432, 小田切, 優樹, 9000020411356, 若松, 志保, 45131, 田先, 由佳, 北村, 健一郎, 9000003077192, 45129, 門脇, 大介, 45124, 丸山, 徹, 1000070433000, 9000014625989, 9000014580888, Gebicki, Janusz M, 45141, 45140   +26 more
core   +1 more source

A rare mental foramen variation and the role of cone‐beam computed tomography in preventing nerve injury: A case report

Clinical Advances in Periodontics, Volume 16, Issue 2, Page 374-380, June 2026.
Abstract Background The interforaminal space is frequently used for dental implant placement due to its strategic location between the bilateral mental foramina. However, neurosensory disturbances following surgical intervention near the mental foramen (MF) can occur in up to 43% of cases.
Magdalena Orlowska, Hend Abulatifa, Muhammad H. A. Saleh, Hom‐Lay Wang   +3 more
wiley   +1 more source

Construction of olmesartan-related compounds.

, 2012
Construction of olmesartan-related compounds.
Keijiro Saku (158635), Masahiro Fujino (158616), Hiroaki Yanagisawa (158628), Shin-ichiro Miura (158599), Hiroyuki Hanzawa (158608), Satoshi Imaizumi (158620), Issei Komuro (48691), Hiroyuki Koike (158631), Naoki Nakao (158613), Yoshino Matsuo (158624), Yoshihiro Kiya (158604), Sadashiva S. Karnik (104786)   +11 more
core   +1 more source

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study

Кардиоваскулярная терапия и профилактика, 1970
Aim. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that used non ...
Kl. O. Stumpe, E. Agabiti-Rosei, T. Zielinski, D. Schremmer, J. Scholze, P. Laeis, P. Schwandt, M. Ludwig   +7 more
doaj  

A comparative study on the pleiotropic effects of Olmesartan and Telmisartan in hypertensive patients with type 2 diabetes mellitus: A randomized, prospective, open labelled, hospital based study [PDF]

Journal of Krishna Institute of Medical Sciences University, 2023
Background: Hypertension and Diabetes Mellitus (DM) are common non-communicable diseases with increasing incidence worldwide. Angiotensin Receptor Blockers (ARBs) have shown to exhibit various pleiotropic effects.
Vineela Karthik N, Sudhakar Kodudula, Punna Sindu, Srisangeetha G   +3 more
doaj  

Impact of Prior Angiotensin‐Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Delirium Incidence in ICU Patients: A Retrospective Study

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims This investigation aimed at exploring the impact that the pre‐existing use of angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) has on the incidence of delirium in patients within the intensive care unit (ICU).
Zhe Li, Shuo Liu, Qihai Wan, Yahui Niu, Yi Yu   +4 more
wiley   +1 more source

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial

, 2013
Takeshi Takami,1 Yoshihiko Saito21Department of Internal Medicine, Clinic Jingumae, Kashihara, Japan; 2First Department of Internal Medicine, Nara Medical University, Kashihara, JapanPurpose: To compare the long-term effects of olmesartan combined with ...
Saito Y, Takami T
core  

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

, 2010
Current hypertension guidelines recommend using two antihypertensive agents when blood pressure (BP) control is not achieved with one single agent. Objective: This study was designed to assess the antihypertensive benefit of the olmesartan medoxomil 40mg/
Melani L, Schumacher K., Baszak J, Fogari R, Holm Bentzen M, TADDEI, STEFANO   +5 more
core   +1 more source

Olmesartan (Benicar) for hypertension

, 2005
Olmesartan (Benicar) is an angiotensin-II receptor blocker (ARB) labeled for the treatment of hypertension as monotherapy or in combination with other antihypertensive agents.
Ward, Kristina E., Hume, L.
core   +1 more source

Olmesartan: A Little-Known Cause of Diarrhoea [PDF]

, 2019
Olmesartan´s sprue-like enteropathy was first described in 2012 and typically presents with diarrhoea, weight loss, nausea, vomiting, low albumin and histological evidence of intestinal villous atrophy.
Ferreira, António, Veiga, Manuel, Serôdio, Joana, Carneiro, Joana   +3 more
core   +1 more source